450 related articles for article (PubMed ID: 29449184)
1. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
2. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
[TBL] [Abstract][Full Text] [Related]
3. Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
Clin Neurol Neurosurg; 2020 Aug; 195():105951. PubMed ID: 32492588
[TBL] [Abstract][Full Text] [Related]
4. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
6. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
7. Urinary dysfunction and motor symptoms in untreated Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Tajima Y
J Neurol Sci; 2016 Jun; 365():147-50. PubMed ID: 27206894
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
Benamer HT; Patterson J; Wyper DJ; Hadley DM; Macphee GJ; Grosset DG
Mov Disord; 2000 Jul; 15(4):692-8. PubMed ID: 10928580
[TBL] [Abstract][Full Text] [Related]
9. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
11. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
12. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
[TBL] [Abstract][Full Text] [Related]
13. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
14. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
15. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
16. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
17. Association between heart rate variability and striatal dopamine depletion in Parkinson's disease.
Kitagawa T; Umehara T; Oka H; Shiraishi T; Sato T; Takatsu H; Nakahara A; Matsuno H; Bono K; Omoto S; Murakami H; Sengoku R; Iguchi Y
J Neural Transm (Vienna); 2021 Dec; 128(12):1835-1840. PubMed ID: 34559319
[TBL] [Abstract][Full Text] [Related]
18. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
19. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
20. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.
Eggers C; Kahraman D; Fink GR; Schmidt M; Timmermann L
Mov Disord; 2011 Feb; 26(3):416-23. PubMed ID: 21264942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]